Wang, Fangming
Zhang, Gang
Xu, Tianli
Ma, Jianlin
Wang, Jing
Liu, Shuai
Tang, Yuzhe
Jin, Song
Li, Jianxing
Xing, Nianzeng
Funding for this research was provided by:
National Key R&D Program of China (2022YFE0200800)
Research Fund for Tumors of Urinary System treatment in China (020)
Article History
Received: 17 October 2023
Accepted: 12 January 2024
First Online: 20 January 2024
Declarations
:
: The studies involving animals and human participants were reviewed and approved by the Ethical Committee of Beijing Tsinghua Changgung Hospital and National Cancer Center (Ethical approval number: NCC2021C-535).
: Not applicable.
: The authors declare no competing interests.